Diaphragmatic dysfunction and dyspnoea in amyotrophic lateral sclerosis

Area of Science:

• Neurology
• Respiratory Medicine
• Physiology

Background:

• Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease.
• Respiratory failure, often due to diaphragm dysfunction, is the primary cause of mortality in ALS.
• Dyspnoea (shortness of breath) is a major symptom causing significant patient discomfort.

Purpose of the Study:

• To investigate diaphragm function in amyotrophic lateral sclerosis (ALS) patients.
• To determine the relationship between diaphragm dysfunction and the severity of dyspnoea in ALS.
• To identify predictors of dyspnoea in ALS patients.

Main Methods:

• Evaluated 48 ALS patients, stratifying them into dyspnoeic and non-dyspnoeic groups.
• Performed comprehensive respiratory assessments including pulmonary function tests, static pressures, and mouth twitch pressures (Pm,t).
• Utilized electromyographic responses to phrenic nerve and cortical magnetic stimulation, and assessed for abdominal paradox and respiratory pulse.

Main Results:

• Dyspnoeic ALS patients exhibited significantly lower vital capacity, maximal static inspiratory pressure, and Pm,t compared to non-dyspnoeic patients.
• Abdominal paradox and abnormal electromyographic responses to nerve stimulation were significantly more frequent in dyspnoeic patients.
• Multivariate analysis identified signs of diaphragm dysfunction, specifically abdominal paradox and abnormal electromyographic responses, as significant predictors of dyspnoea.

Conclusions:

• Diaphragm dysfunction is a key factor contributing to dyspnoea in amyotrophic lateral sclerosis (ALS).
• Clinical signs such as abdominal paradox and abnormal electrophysiological responses indicate impaired diaphragm function.
• Diaphragm function testing should be considered in the clinical evaluation of ALS patients experiencing dyspnoea.